High Response to Cetuximab in a Patient With EGFR-Amplified Heavily Pretreated Metastatic Triple-Negative Breast Cancer.
Sabatier R, Lopez M, Guille A, Billon E, Carbuccia N, Garnier S, Adelaide J, Extra JM, Cappiello MA, Charafe-Jauffret E, Pakradouni J, Viens P, Gonçalves A, Chaffanet M, Birnbaum D, Bertucci F.
Sabatier R, et al. Among authors: cappiello ma.
JCO Precis Oncol. 2019 Dec;3:1-8. doi: 10.1200/PO.18.00310.
JCO Precis Oncol. 2019.
PMID: 35100682
No abstract available.